Spots Global Cancer Trial Database for Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)
Official Title: A Phase III Placebo-Controlled Trial Of Celecoxib In Genotype Positive Subjects With Familial Adenomatous Polyposis
Study ID: NCT00585312
Conditions
Study Description
Brief Summary: To test whether celecoxib can be used to prevent colon polyp formation in children with familial adenomatous polyposis (FAP).
Detailed Description: Per DMC recommendation, the study was terminated early (31Oct2013) due to low enrollment and low endpoint accumulation rate. No safety concerns were involved in the decision to terminate the study.
Keywords
Eligibility
Minimum Age: 10 Years
Eligible Ages: CHILD
Sex: ALL
Healthy Volunteers: No
Locations
Pfizer Investigational Site, Chicago, Illinois, United States
Pfizer Investigational Site, Ann Arbor, Michigan, United States
Pfizer Investigational Site, Omaha, Nebraska, United States
Pfizer Investigational Site, New York, New York, United States
Pfizer Investigational Site, New York, New York, United States
Pfizer Investigational Site, New York, New York, United States
Pfizer Investigational Site, Chagrin Falls, Ohio, United States
Pfizer Investigational Site, Cincinnati, Ohio, United States
Pfizer Investigational Site, Cleveland, Ohio, United States
Pfizer Investigational Site, Cleveland, Ohio, United States
Pfizer Investigational Site, Elyria, Ohio, United States
Pfizer Investigational Site, Independence, Ohio, United States
Pfizer Investigational Site, Lakewood, Ohio, United States
Pfizer Investigational Site, Lorain, Ohio, United States
Pfizer Investigational Site, Solon, Ohio, United States
Pfizer Investigational Site, Strongsville, Ohio, United States
Pfizer Investigational Site, Westlake, Ohio, United States
Pfizer Investigational Site, Willoughby Hills, Ohio, United States
Pfizer Investigational Site, Wooster, Ohio, United States
Pfizer Investigational Site, Nashville, Tennessee, United States
Pfizer Investigational Site, Houston, Texas, United States
Pfizer Investigational Site, Salt Lake City, Utah, United States
Pfizer Investigational Site, Salt Lake City, Utah, United States
Pfizer Investigational Site, Bruxelles, , Belgium
Pfizer Investigational Site, Gent, , Belgium
Pfizer Investigational Site, Praha 5, , Czechia
Pfizer Investigational Site, Praha, , Czechia
Pfizer Investigational Site, Shatin, New Territories, Hong Kong
Pfizer Investigational Site, Hong Kong, , Hong Kong
Pfizer Investigational Site, Miskolc, , Hungary
Pfizer Investigational Site, Haifa, , Israel
Pfizer Investigational Site, M.P. Lower Galilee, , Israel
Pfizer Investigational Site, Petach Tikvah 49202, , Israel
Pfizer Investigational Site, Tel Aviv, , Israel
Pfizer Investigational Site, Roma, , Italy
Pfizer Investigational Site, Siena, , Italy
Pfizer Investigational Site, Rio Piedras, , Puerto Rico
Pfizer Investigational Site, Bratislava, , Slovakia
Pfizer Investigational Site, Cape Town, Western Cape, South Africa, South Africa
Pfizer Investigational Site, Madrid, , Spain
Pfizer Investigational Site, Stockholm, , Sweden
Pfizer Investigational Site, Donetsk, , Ukraine
Pfizer Investigational Site, Harrow, Middlesex, England, United Kingdom
Contact Details
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
